Newtyn Management, LLC Theravance Biopharma, Inc. Transaction History

Newtyn Management, LLC

  • $507 Million
  • Q1 2025

A detailed history of Newtyn Management, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Newtyn Management, LLC holds 4,757,403 shares of TBPH stock, worth $54 Million. This represents 8.37% of its overall portfolio holdings.

Number of Shares
4,757,403
Previous 4,757,403 -0.0%
Holding current value
$54 Million
Previous $44.8 Million 5.1%
% of portfolio
8.37%
Previous 9.1%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$7.93 - $10.08 $2.05 Million - $2.6 Million
258,337 Added 5.74%
4,757,403 $44.8 Million
Q3 2024

Nov 14, 2024
BUY
$7.66 - $10.25 $18.2 Million - $24.3 Million
2,374,363 Added 111.75%
4,499,066 $36.3 Million
Q2 2024

Aug 14, 2024
BUY
$8.29 - $9.92 $3.99 Million - $4.77 Million
480,773 Added 29.25%
2,124,703 $18 Million
Q1 2024

May 15, 2024
SELL
$8.22 - $11.59 $2.1 Million - $2.97 Million
-256,070 Reduced 13.48%
1,643,930 $14.7 Million
Q4 2023

Feb 14, 2024
BUY
$8.58 - $11.4 $501,415 - $666,216
58,440 Added 3.17%
1,900,000 $21.4 Million
Q3 2023

Nov 14, 2023
BUY
$8.38 - $10.44 $1.69 Million - $2.1 Million
201,104 Added 12.26%
1,841,560 $15.9 Million
Q2 2023

Aug 14, 2023
BUY
$10.16 - $11.92 $1.11 Million - $1.3 Million
109,441 Added 7.15%
1,640,456 $17 Million
Q1 2023

May 15, 2023
BUY
$9.87 - $11.44 $799,618 - $926,811
81,015 Added 5.59%
1,531,015 $16.6 Million
Q4 2022

Feb 14, 2023
SELL
$9.65 - $11.34 $10.1 Million - $11.9 Million
-1,045,860 Reduced 41.9%
1,450,000 $16.3 Million
Q3 2022

Nov 14, 2022
BUY
$8.39 - $10.22 $3.84 Million - $4.68 Million
458,035 Added 22.48%
2,495,860 $25.3 Million
Q2 2022

Aug 15, 2022
BUY
$8.41 - $10.34 $5.57 Million - $6.85 Million
662,825 Added 48.21%
2,037,825 $18.5 Million
Q1 2022

May 16, 2022
BUY
$8.33 - $12.96 $3.12 Million - $4.86 Million
375,000 Added 37.5%
1,375,000 $13.1 Million
Q4 2021

Feb 14, 2022
BUY
$7.42 - $11.05 $6.69 Million - $9.97 Million
902,045 Added 920.88%
1,000,000 $11.1 Million
Q3 2021

Nov 15, 2021
BUY
$6.77 - $14.41 $663,155 - $1.41 Million
97,955 New
97,955 $725,000
Q1 2020

May 15, 2020
SELL
$17.84 - $31.21 $3.09 Million - $5.41 Million
-173,300 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$16.12 - $25.89 $1.77 Million - $2.84 Million
109,619 Added 172.14%
173,300 $4.49 Million
Q3 2019

Nov 14, 2019
BUY
$16.51 - $23.78 $1.05 Million - $1.51 Million
63,681 New
63,681 $1.24 Million

Others Institutions Holding TBPH

# of Institutions
137
Shares Held
47.3M
Call Options Held
700
Put Options Held
1.4K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $758M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Newtyn Management, LLC Portfolio

Follow Newtyn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email